View in EDS

Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.

Saved in:

Bibliographic Details
Title:	Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.
Authors:	Piperno GM; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., López-Requena A; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.; Immunobiology Division, Center of Molecular Immunology, Havana, Cuba., Predonzani A; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Dorvignit D; Immunobiology Division, Center of Molecular Immunology, Havana, Cuba., Labrada M; Immunobiology Division, Center of Molecular Immunology, Havana, Cuba., Zentilin L; Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Burrone OR; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy., Cesco-Gaspere M; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Source:	Gene therapy [Gene Ther] 2015 Dec; Vol. 22 (12), pp. 960-7. Date of Electronic Publication: 2015 Jul 16.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1476-5462
DOI:	10.1038/gt.2015.71